Literature DB >> 18094346

Timing of blood pressure measurement related to caffeine consumption.

Jane R Mort1, Heather R Kruse.   

Abstract

OBJECTIVE: To determine whether patients should wait 30 minutes after caffeine consumption to have their blood pressure measured. DATA SOURCES: Literature was obtained by searching MEDLINE (1980-September 2007), International Pharmaceutical Abstracts (1980-September 2007), and the Cochrane Database of Systematic Reviews (1994-September 2007). Search terms included caffeine and blood pressure. Literature was also obtained from citations in relevant articles. STUDY SELECTION AND DATA EXTRACTION: Articles that examined caffeine's acute effect on blood pressure were reviewed, with additional focus on caffeine tolerance and hypertensive status. DATA SYNTHESIS: Caffeine appears to affect blood pressure through adenosine receptor inhibition and an increased release of select neurotransmitters. Caffeine levels peak 30-120 minutes after oral intake and caffeine's half-life is 3-6 hours. The effect of caffeine on blood pressure has been examined for decades, with variable results depending on factors such as population examined (eg, hypertensive status, physical stressors, age) and study design (eg, acute effects, chronic ingestion, retrospective epidemiologic review). Caffeine tolerance diminishes the acute effect of caffeine on blood pressure, and hypertensive individuals are more susceptible to blood pressure changes. Reviews of caffeine's acute effect on blood pressure indicate changes of 3-15 mm Hg systolic and 4-13 mm Hg diastolic. Typically, blood pressure changes occur within 30 minutes, peak in 1-2 hours, and may persist for more than 4 hours.
CONCLUSIONS: Having a patient abstain from caffeine for 30 minutes prior to blood pressure monitoring is not adequate to avoid caffeine's potential effects. An alternative approach to blood pressure monitoring would be to ask the patient about recent caffeine consumption and interpret the blood pressure reading based on this information. In addition, healthcare practitioners should provide education regarding caffeine's effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094346     DOI: 10.1345/aph.1K337

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  20 in total

1.  Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery.

Authors:  Marina Roizenblatt; Vitor Dias Gomes Barrios Marin; Alex Treiger Grupenmacher; Felipe Muralha; Jean Faber; Kim Jiramongkolchai; Peter Louis Gehlbach; Michel Eid Farah; Rubens Belfort; Mauricio Maia
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

Review 2.  [Coffee and cardiovascular diseases].

Authors:  Mariano de la Figuera von Wichmann
Journal:  Aten Primaria       Date:  2009-09-23       Impact factor: 1.137

3.  Reproducibility of retrobulbar blood flow velocity measurements in normal subjects using two different CDI devices.

Authors:  Carolina Dellafiore; Massimiliano Lava; Alice Chandra Verticchio Vercellin; Carlo Alberto Cutolo; Carmine Tinelli; Annalisa De Silvestri; Fabrizio Calliada; Giovanni Milano
Journal:  Radiol Med       Date:  2015-02-19       Impact factor: 3.469

4.  An epidermal patch for the simultaneous monitoring of haemodynamic and metabolic biomarkers.

Authors:  Juliane R Sempionatto; Muyang Lin; Lu Yin; Ernesto De la Paz; Kexin Pei; Thitaporn Sonsa-Ard; Andre N de Loyola Silva; Ahmed A Khorshed; Fangyu Zhang; Nicholas Tostado; Sheng Xu; Joseph Wang
Journal:  Nat Biomed Eng       Date:  2021-02-15       Impact factor: 25.671

5.  Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults.

Authors:  LaBarron K Hill; Andrew Sherwood; Maya McNeilly; Norman B Anderson; James A Blumenthal; Alan L Hinderliter
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

6.  Quantitative mapping of cerebrovascular reactivity using resting-state BOLD fMRI: Validation in healthy adults.

Authors:  Ali M Golestani; Luxi L Wei; J Jean Chen
Journal:  Neuroimage       Date:  2016-05-11       Impact factor: 6.556

7.  Effects of caffeinated coffee consumption on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude: a randomized controlled trial.

Authors:  A Z Jiwani; D J Rhee; S C Brauner; M F Gardiner; T C Chen; L Q Shen; S H Chen; C L Grosskreutz; K K Chang; C E Kloek; S H Greenstein; S Borboli-Gerogiannis; D L Pasquale; S Chaudhry; S Loomis; J L Wiggs; L R Pasquale; A V Turalba
Journal:  Eye (Lond)       Date:  2012-06-08       Impact factor: 3.775

8.  Interaction between drug and placebo effects: a cross-over balanced placebo design trial.

Authors:  Muhammad M Hammami; Eman A Al-Gaai; Syed Alvi; Muhammad B Hammami
Journal:  Trials       Date:  2010-11-19       Impact factor: 2.279

9.  Caffeine ingestion alters central hemodynamics following aerobic exercise in middle-aged men.

Authors:  Matthew P Harber; Allison McCurry; Nicholas Carlini; Brandon Kistler; Bradley S Fleenor
Journal:  Eur J Appl Physiol       Date:  2020-10-24       Impact factor: 3.078

Review 10.  Caffeine and cardiovascular diseases: critical review of current research.

Authors:  Anthony Zulli; Renee M Smith; Peter Kubatka; Jan Novak; Yoshio Uehara; Hayley Loftus; Tawar Qaradakhi; Miroslav Pohanka; Nazarii Kobyliak; Angela Zagatina; Jan Klimas; Alan Hayes; Giampiero La Rocca; Miroslav Soucek; Peter Kruzliak
Journal:  Eur J Nutr       Date:  2016-03-01       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.